Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning

被引:72
|
作者
Moraes, Gabriella [1 ,2 ]
Fu, Dun Jack [1 ,2 ]
Wilson, Marc [3 ]
Khalid, Hagar [1 ,2 ]
Wagner, Siegfried K. [1 ,2 ]
Korot, Edward [1 ,2 ]
Ferraz, Daniel [1 ,2 ,4 ]
Faes, Livia [1 ,2 ]
Kelly, Christopher J. [3 ]
Spitz, Terry [3 ]
Patel, Praveen J. [1 ,2 ]
Balaskas, Konstantinos [1 ,2 ]
Keenan, Tiarnan D. L. [5 ]
Keane, Pearse A. [1 ,2 ]
Chopra, Reena [1 ,2 ,3 ]
机构
[1] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England
[2] UCL Inst Ophthalmol, London, England
[3] Google Hlth, London, England
[4] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil
[5] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA
关键词
age-related macular degeneration; neovascular; deep learning; OCT; automated; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIAL DETACHMENT; VISUAL-ACUITY; THICKNESS MEASUREMENTS; HYPERREFLECTIVE FOCI; RETINAL THICKNESS; SUBRETINAL FLUID; DOSING REGIMEN; RANIBIZUMAB; SEGMENTATION;
D O I
10.1016/j.ophtha.2020.09.025
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To apply a deep learning algorithm for automated, objective, and comprehensive quantification of OCT scans to a large real-world dataset of eyes with neovascular age-related macular degeneration (AMD) and make the raw segmentation output data openly available for further research. Design: Retrospective analysis of OCT images from the Moorfields Eye Hospital AMD Database. Participants: A total of 2473 first-treated eyes and 493 second-treated eyes that commenced therapy for neovascular AMD between June 2012 and June 2017. Methods: A deep learning algorithm was used to segment all baseline OCT scans. Volumes were calculated for segmented features such as neurosensory retina (NSR), drusen, intraretinal fluid (IRF), subretinal fluid (SRF), subretinal hyperreflective material (SHRM), retinal pigment epithelium (RPE), hyperreflective foci (HRF), fibro-vascular pigment epithelium detachment (fvPED), and serous PED (sPED). Analyses included comparisons between first- and second-treated eyes by visual acuity (VA) and race/ethnicity and correlations between volumes. Main Outcome Measures: Volumes of segmented features (mm(3)) and central subfield thickness (CST) (mm). Results: In first-treated eyes, the majority had both IRF and SRF (54.7%). First-treated eyes had greater volumes for all segmented tissues, with the exception of drusen, which was greater in second-treated eyes. In first-treated eyes, older age was associated with lower volumes for RPE, SRF, NSR, and sPED; in second-treated eyes, older age was associated with lower volumes of NSR, RPE, sPED, fvPED, and SRF. Eyes from Black individuals had higher SRF, RPE, and serous PED volumes compared with other ethnic groups. Greater volumes of the majority of features were associated with worse VA. Conclusions: We report the results of large-scale automated quantification of a novel range of baseline features in neovascular AMD. Major differences between first- and second-treated eyes, with increasing age, and between ethnicities are highlighted. In the coming years, enhanced, automated OCT segmentation may assist personalization of real-world care and the detection of novel structure-function correlations. These data will be made publicly available for replication and future investigation by the AMD research community. (C) 2020 by the American Academy of Ophthalmology.
引用
收藏
页码:693 / 705
页数:13
相关论文
共 50 条
  • [21] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [22] Quantitative analysis of change in retinal tissues in neovascular age-related macular degeneration using artificial intelligence
    Chopra, Reena
    Moraes, Gabriella
    Fu, Dun Jack
    Wagner, Siegfried
    Spitz, Terry
    Wilson, Marc
    Yim, Jason
    Winkens, Jim
    De Fauw, Jeffrey
    Ledsam, Joseph R.
    Kelly, Christopher J.
    Keenan, Tiarnan D. L.
    Patel, Praveen J.
    Balaskas, Konstantinos
    Keane, Pearse Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [23] Imaging in Neovascular Age-Related Macular Degeneration
    Gess, Adam J.
    Fung, Anne E.
    Rodriguez, Jorge G.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 225 - 233
  • [24] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [25] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Sivagnanavel, Vasuki
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [26] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [27] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [28] β-blockers and Neovascular Age-related Macular Degeneration
    Yeung, Ling
    Huang, Ting-Shuo
    Lin, Yun-Hsuan
    Hsu, Kuang-Hung
    Huang, Jerry Chien-Chieh
    Sun, Chi-Chin
    OPHTHALMOLOGY, 2017, 124 (03) : 409 - 411
  • [29] Deep learning is effective in classifying normal versus Age-related Macular degeneration using OCT images
    Lee, Aaron Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [30] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466